MedPath

Effect of Gabapentin on Idiopathic Subjective Tinnitus

Phase 2
Conditions
Subjective Tinnitus
Interventions
Drug: placebo
Registration Number
NCT00555776
Lead Sponsor
Islamic Azad University of Mashhad
Brief Summary

The purpose of this study is to determine wether Gabapentin which is useful for treating neuropathic pains, is effective on idiopathic subjective tinnitus.

Detailed Description

Tinnitus is the perception of sound in the absence of acoustic stimulation. It can be subjective or objective. .

Despite numerous researches,no effective treatment for people who suffer from tinnitus has yet been stablished.

As there are many evidences suggesting that loss of inhibition in the central nervous system may be responsible for many aspects of auditory dysfunction,including tinnitus; and as Gabapentin (Neurontin), a gama-aminobutyric acid (GABA) analogue, is an effective medication in conditions where inhibition in the CNS is impaired; we guess that Gabapentin might be useful for treating idiopathic subjective tinnitus.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • patients with subjective idiopathic tinnitus
Exclusion Criteria
  • tinnitus with known underlying cause
  • pregnant women and patients younger than 18 or older than 75 years
  • patients with impaired renal function

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2placeboRandomly,half of the subjects receive placebo.
1GabapentinRandomly,half of the subjects are given Gabapentin.
Primary Outcome Measures
NameTimeMethod
Reduction in the sensation of Tinnitus by the patient or complete resolution of tinnitus;by the patient's scoring it from one to ten, before and after prescribing Gabapentin.two months
Secondary Outcome Measures
NameTimeMethod
Relieve of complications of tinnitus, such as sleep difficulties.two months

Trial Locations

Locations (1)

ENT department of Mashhad Azad medical university

🇮🇷

Mashhad, Khorasan razavi, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath